arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Lucid Diagnostics Inc.

LUCD

$0.97 ▲ +0.01 (+1.22%) at close

25 Visible periods

28 Metrics

Absolute Benchmarks

Price Chart

Health

Weak

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Lucid Diagnostics Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $135.9M

Dividend Yield —

Revenue Growth 51.7%

Op. Margin —

ROIC -302.9% ↘

FCF / Share $-0.09

Trailing P/E —

Price / Book 40.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

25-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$1.26M

↑ +51.7% —

Net Income Profit after all expenses

$-13.91M

↑ +48.3% —

FCF / Share Free cash flow per share

$-0.09

↑ +51.5% —

Long-Term Debt Long-term obligations

$24.28M

↑ +126.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -453.9% is weak on an absolute basis (target > 10%)
FCF / Net IncomeFCF / Net Income of 0.80x is caution on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Revenue Growth YoY (%)	51.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+546%)	—	3.3% Caution ↑ Caution Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-58%)	19.2% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+139%)	-17.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-316%)	—	49.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+521%)	513.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6323%)	124.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1455%)	828.6% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+10257%)	930.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11528%)	—	136.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1600%)	—	-62.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-875%)	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	67.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	44.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	60.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	65.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-30.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	28.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	26.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	14.8% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	12.8% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	34.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-14.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-25.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	6.8% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	-34.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	48.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-40.9% Weak ↓ Weak Declining Year-over-year change in net income	16.0% Good ↑ Good Improving Year-over-year change in net income	59.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-153.6% Weak ↓ Weak Declining Year-over-year change in net income	-6.6% Weak ↓ Weak Declining Year-over-year change in net income	12.9% Fair ↓ Fair Declining Year-over-year change in net income	3.3% Caution ↓ Caution Declining Year-over-year change in net income	34.7% Excellent ↑ Excellent Improving Year-over-year change in net income	27.5% Excellent ↑ Excellent Improving Year-over-year change in net income	1.0% Caution ↑ Caution Improving Year-over-year change in net income	22.2% Good ↑ Good Improving Year-over-year change in net income	-32.4% Weak ↑ Weak Improving Year-over-year change in net income	-32.0% Weak ↑ Weak Improving Year-over-year change in net income	-106.3% Weak ↑ Weak Improving Year-over-year change in net income	-137.3% Weak ↑ Weak Improving Year-over-year change in net income	-235.9% Weak ↑ Weak Improving Year-over-year change in net income	-314.0% Weak Weak Year-over-year change in net income	-244.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	51.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	35.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-62.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-2.2% Weak Weak Year-over-year change in free cash flow	—	—	—	28.4% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	41.2% Excellent Excellent Compound annual revenue growth over 3 years	—	151.6% Excellent Excellent Compound annual revenue growth over 3 years	—	63.6% Excellent Excellent Compound annual revenue growth over 3 years	—	80.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Effective Tax Rate (%) (%)	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	-381.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3281%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.89x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.05x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	2.38x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.19x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.43x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.29x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.37x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Return on Invested Capital (%)	-302.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-101.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-114.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	183.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-181.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-145.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-71.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	391.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-343.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-45.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-51.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-3468.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	23.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	17.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	16.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	2630.8% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-35.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-40.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-51.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-42.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-27.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-29.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-32.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-197.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-124.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	—	-148.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1092%)	-40.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-368%)	-56.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-476%)	—	-214.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1527%)	-195.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1401%)	-68.9% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-559%)	-89.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-695%)	—	—	-75.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-603%)	-65.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-535%)	-64.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-532%)	-52.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-447%)	-40.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-369%)	-26.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-276%)	-20.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	28.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+92%)	30.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+106%)	22.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+49%)	20.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+35%)	18.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+25%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-1.01x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-268%)	—	—	—	-0.99x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-266%)	—	-1.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-267%)
Interest Coverage (x)	—	—	-5879.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1897.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1387.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-11694.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1865.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-899.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1041.18x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-74.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-51.95x Weak Weak Operating income divided by interest expense Optimal: > 5x	-433.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	-172.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.57x Weak Weak Operating income divided by interest expense Optimal: > 5x	-40.93x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	—	—	$-47.33M	$-31.12M	$-25.24M	—	$-14.49M	$-24.92M	$-24.77M	$-18.90M	$-24.05M	$-32.57M	$-39.52M	$-22.47M	$-26.93M	—	—	$-53.66M	$24.28M	—	—	—	$10.74M	—	$5.32M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-3.73x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	-5.31x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Revenue per Share (USD)	$0.01	—	$0.01	$0.01	$0.01	—	$0.02	$0.02	$0.02	—	$0.02	$0.00	$0.01	—	$0.00	—	$0.01	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.17	$-0.10	$-0.10	$-0.08	$-0.52	$-0.18	$-0.25	$-0.23	$-0.40	$-0.25	$-0.34	$-0.27	$-0.40	$-0.40	$-0.39	$-0.41	$-0.35	$-0.32	—	$-0.44	$-0.26	—	—	—	—
Free Cash Flow per Share (USD)	$-0.09	—	$-0.10	$-0.11	$-0.18	—	—	—	$-0.28	—	—	—	$-0.17	—	—	—	$-0.17	—	—	$-0.16	$-0.24	—	—	—	—
Book Value per Share (USD)	$0.02	$0.08	$0.20	$0.08	$-0.06	$0.09	$0.12	$0.32	$0.25	$-0.05	$0.06	$0.36	$0.60	$0.57	$0.74	$1.01	$1.32	$1.57	$-1.71	$-1.41	$-1.16	$-0.96	—	—	—
Tangible Book Value per Share (USD)	$0.02	$0.08	$0.19	$0.07	$-0.07	$0.07	$0.11	$0.30	$0.23	$-0.09	$0.01	$0.30	$0.53	$0.48	$0.64	$0.88	$1.16	$1.57	$-1.71	$-1.41	$-1.16	$-0.96	—	—	—
Basic Weighted Avg Shares (shares)	140.10M	—	108.18M	98.99M	68.80M	—	50.37M	48.21M	45.01M	—	41.86M	41.83M	40.97M	—	36.41M	35.76M	35.12M	—	—	14.11M	14.11M	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Working Capital (USD)	$1.98M	$8.89M	$23.64M	$4.41M	$-9.03M	$1.62M	$2.58M	$11.97M	$7.61M	$-7.31M	$-2.92M	$9.07M	$18.33M	$15.93M	$20.15M	$28.00M	$38.22M	$53.04M	—	—	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$24.28M	—	—	—	$10.74M	—	$5.32M
Total Equity (USD)	$4.00M	$10.94M	$25.84M	$7.86M	$-5.38M	$5.39M	$6.34M	$15.98M	$11.89M	$-2.31M	$2.56M	$15.07M	$24.91M	$23.05M	$27.53M	$36.24M	$46.49M	$54.74M	$-24.13M	$-19.95M	$-16.37M	$-13.52M	$-10.80M	$-8.80M	$-5.31M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-Q ↗
Sales/Revenue/Turnover (USD)	$1.26M	—	$1.21M	$1.16M	$828.00K	—	$1.17M	$976.00K	$1.00M	$1.04M	$783.00K	$159.00K	$446.00K	$112.00K	$76.00K	—	$189.00K	—	$200.00K	—	—	—	—	—	—
Depreciation Expense (USD)	$222.00K	$209.00K	$220.00K	$222.00K	$221.00K	$222.00K	—	—	$501.00K	$629.00K	—	—	$612.00K	$615.00K	—	—	$24.00K	$1.00K	—	—	$3.00K	—	—	—	—
Net Income, GAAP (USD)	$-13.91M	$-16.27M	$-10.40M	$-4.44M	$-26.91M	$-11.54M	$-12.37M	$-11.01M	$-10.61M	$-10.83M	$-14.21M	$-11.38M	$-16.25M	$-14.93M	$-14.35M	$-14.62M	$-12.27M	$-11.31M	$-6.96M	$-6.16M	$-3.65M	$-2.73M	$-2.02M	—	—
Operating Cash Flow (USD)	$-12.10M	$-12.58M	$-10.89M	$-10.55M	$-12.46M	$-9.87M	—	—	$-12.61M	$-9.98M	—	—	$-7.04M	$-4.26M	—	—	$-5.78M	$-9.88M	—	$-2.29M	$-3.31M	$-1.68M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters

Lucid Diagnostics Inc.

Analytical Summary

25-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare LUCD with peers